# Effect of Omega 3 on Atrophic Vaginitis in Breast Cancer Survivors

> **NCT02150525** · PHASE2 · COMPLETED · sponsor: **Ohio State University Comprehensive Cancer Center** · enrollment: 52 (actual)

## Conditions studied

- Ductal Breast Carcinoma in Situ
- Breast Cancer, Stage I
- Breast Cancer, Stage II
- Breast Cancer, Stage III

## Interventions

- **DIETARY_SUPPLEMENT:** omega-3 fatty acid
- **OTHER:** placebo
- **BEHAVIORAL:** Questionnaire administration

## Key facts

- **NCT ID:** NCT02150525
- **Lead sponsor:** Ohio State University Comprehensive Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-08
- **Primary completion:** 2013-01
- **Final completion:** 2013-01
- **Target enrollment:** 52 (ACTUAL)
- **Last updated:** 2018-08-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02150525

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02150525, "Effect of Omega 3 on Atrophic Vaginitis in Breast Cancer Survivors". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02150525. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*